Literature DB >> 11012158

The role of endothelium in the regulation of hematopoietic stem cell migration.

R Möhle1, S Rafii, M A Moore.   

Abstract

Mobilization of hematopoietic progenitor cells appears to be a multifactorial process which is at least partially regulated at the level of bone marrow microvascular endothelium (BMEC). In order to study the regulation of progenitor cell migration by endothelium in vitro, methods have been developed to isolate BMEC from bone marrow aspirates. In addition, immortalized BMEC cell lines have been generated. Using an in vitro model of migration across bone marrow endothelium, we demonstrate that only a small number of more mature, committed progenitors migrate spontaneously. In this model, adhesion molecules of the beta2-integrin family and the corresponding endothelial ligands are involved. The low spontaneous migratory capacity suggests that, in addition to adhesion molecules which mediate direct cellular contacts, paracrine cytokines and chemokines may play a role in progenitor migration across endothelium. Growth-factor-stimulated hematopoietic cells can produce cytokines which act on endothelial cells (e.g., vascular endothelial growth factor, VEGF), modifying their motility, growth, permeability, and fenestration. Therefore, VEGF might be involved in the mobilization and homing of hematopoietic progenitor cells. Furthermore, transendothelial migration of progenitors in vitro is substantially enhanced by the chemokine stromal-cell-derived factor-1 (SDF-1), which is produced by bone marrow stromal cells. More primitive progenitors, which do not migrate spontaneously, also respond to this chemokine. We conclude that transendothelial progenitor cell migration is regulated by adhesion molecules, paracrine cytokines, and chemokines. Mobilizing hematopoietic growth factors stimulate proliferation of hematopoietic cells, which may indirectly result in changes of the local cytokine and chemokine milieu, adhesion molecule expression, and eventually the mobilization of hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11012158     DOI: 10.1002/stem.5530160819

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  5 in total

Review 1.  CXCL12 in control of neuroinflammation.

Authors:  Miljana Momcilović; Marija Mostarica-Stojković; Djordje Miljković
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Authors:  Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

3.  CXCR4 but not CXCR7 is mainly implicated in ocular leukocyte trafficking during ovalbumin-induced acute uveitis.

Authors:  Zili Zhang; Wenwei Zhong; Mark J Hall; Peter Kurre; Doran Spencer; Amy Skinner; Stacy O'Neill; Zhenwei Xia; James T Rosenbaum
Journal:  Exp Eye Res       Date:  2009-06-12       Impact factor: 3.467

4.  Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.

Authors:  Jelena Põlajeva; Anna M Sjösten; Nina Lager; Marianne Kastemar; Ida Waern; Irina Alafuzoff; Anja Smits; Bengt Westermark; Gunnar Pejler; Lene Uhrbom; Elena Tchougounova
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

5.  Engineering a multicellular vascular niche to model hematopoietic cell trafficking.

Authors:  Surya S Kotha; Brian J Hayes; Kiet T Phong; Meredith A Redd; Karol Bomsztyk; Aravind Ramakrishnan; Beverly Torok-Storb; Ying Zheng
Journal:  Stem Cell Res Ther       Date:  2018-03-23       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.